Nostrum Labs Inc Company Profile
✉ Email this page to a colleague
What is the competitive landscape for NOSTRUM LABS INC, and what generic and branded alternatives to NOSTRUM LABS INC drugs are available?
NOSTRUM LABS INC has fifty-two approved drugs.
Drugs and US Patents for Nostrum Labs Inc
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Nostrum Labs Inc | PIROXICAM | piroxicam | CAPSULE;ORAL | 074118-002 | Jun 15, 1993 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Nostrum Labs Inc | CLARITHROMYCIN | clarithromycin | TABLET, EXTENDED RELEASE;ORAL | 203243-001 | Feb 29, 2016 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Nostrum Labs Inc | ACETAMINOPHEN AND CODEINE PHOSPHATE | acetaminophen; codeine phosphate | TABLET;ORAL | 088629-003 | Mar 6, 1985 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | |||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.